Outcome of multiple myeloma patients with Hepatitis surface antigen:Korean Multiple myeloma working party 2103 study

Hepatitis B virus reactivation (HBVr) is a well-known complication of systemic chemotherapy for particularly hematologic malignancies in HBV carriers. We performed a multicenter retrospective study to investigate the incidence and risk factors of HBVr in patients with hepatitis B surface antigen (HBsAg)-positive multiple myeloma (MM).

Source: Clinical Lymphoma, Myeloma and Leukemia - October 14, 2023 Category: Hematology Authors: Jun Ho Yi, Jung Lim Lee, Yoo Jin Lee, Hye Jin Kang, Young Hoon Park, Young Jin Yuh, Sung-Nam Lim, Hyo Jung Kim, Sung-Hoon Jung, Je-Jung Lee, Hee Jeong Cho, Joon Ho Moon, Ho-Young Yhim, Kihyun Kim Tags: Original Study Source Type: research